We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,886 results
  1. Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment

    Oligodendrogliomas characterized and defined by 1p/19q co-deletion are slowly growing tumors showing better prognosis than astrocytomas. TP53 ...

    Fumi Higuchi, Takeo Uzuka, ... Keisuke Ueki in Brain Tumor Pathology
    Article 31 January 2024
  2. A single institution retrospective analysis on survival based on treatment paradigms for patients with anaplastic oligodendroglioma

    Introduction

    Anaplastic oligodendrogliomas are high-grade gliomas defined molecularly by 1p19q co-deletion. There is no curative therapy, and standard...

    Nancy Ann Oberheim Bush, Jacob S. Young, ... Nicholas A. Butowski in Journal of Neuro-Oncology
    Article Open access 14 June 2021
  3. Long-term follow up of patients with WHO grade 2 oligodendroglioma

    Purpose

    Since the introduction of the molecular definition of oligodendrogliomas based on isocitrate dehydrogenase ( IDH )-status and the...

    Louise Carstam, Francesco Latini, ... Asgeir S. Jakola in Journal of Neuro-Oncology
    Article Open access 21 August 2023
  4. Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy

    Oligodendroglioma, IDH-mutant and 1p/19q-codeleted is known for their relative chemosensitivity and indolent clinical course among diffuse gliomas of...

    Hikaru Sasaki, Yohei Kitamura, ... Kazunari Yoshida in Brain Tumor Pathology
    Article 02 April 2024
  5. A patient with two gliomas with independent oligodendroglioma and glioblastoma biology proved by DNA-methylation profiling: a case report and review of the literature

    Here, we report on a patient presenting with two histopathologically distinct gliomas. At the age of 42, the patient underwent initial resection of a...

    Theo F. J. Kraus, Christoph Schwartz, ... Karl Sotlar in Brain Tumor Pathology
    Article Open access 11 January 2022
  6. Apparent diffusion coefficient values effectively predict cell proliferation and determine oligodendroglioma grade

    This study aims to evaluate the value of conventional magnetic resonance imaging (MRI) features and apparent diffusion coefficient (ADC) values in...

    **aoai Ke, Jun Zhao, ... Junlin Zhou in Neurosurgical Review
    Article 06 April 2023
  7. The cortical high-flow sign of oligodendroglioma, IDH-mutant and 1p/19q-codeleted: comparison between arterial spin labeling and dynamic susceptibility contrast methods

    Purpose

    The cortical high-flow sign with the non-enhancing area was reportedly found to be more frequent with oligodendroglioma, IDH-mutant and...

    Koji Yamashita, Osamu Togao, ... Kousei Ishigami in Neuroradiology
    Article 21 December 2023
  8. Extensive anaplastic multi-centric ependymoma in a young adult: case report and literature review

    Background

    Ependymoma is a rare adult tumor that originates from ependymal cells of the ventricles and the spinal cord. The diagnosis and management...

    Lamya Aballa, Mohamed Chraa, ... Najib Kissani in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 15 May 2023
  9. Large tumour volume reduction of IDH-mutated anaplastic glioma involving the insular region following radiotherapy

    Background

    The impact of near-total resection of IDH-mutated anaplastic glioma (IDHmutAG) is well-established but there remains uncertainty of benefit...

    Gabrielle Metz, Dasantha Jayamanne, ... Michael Back in BMC Neurology
    Article Open access 13 January 2022
  10. Long-term outcomes of CNS WHO grade 2 oligodendroglioma in adult patients: a single-institution experience

    Purpose

    Oligodendrogliomas (ODGs) are a subtype of diffuse lower-grade gliomas with overall survival of > 10 years. This study aims to analyze...

    Yukyeng Byeon, Chae** Lee, ... Sang Woo Song in Discover Oncology
    Article Open access 06 July 2024
  11. Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions

    Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in...

    Henri Bogumil, Martin Sill, ... Philipp Sievers in Acta Neuropathologica
    Article Open access 18 March 2023
  12. Phase II Trial of Palbociclib in Recurrent Retinoblastoma-Positive Anaplastic Oligodendroglioma: A Study from the Spanish Group for Research in Neuro-Oncology (GEINO)

    Background

    The cell cycle checkpoint G1/S, dependent on cyclin-dependent kinase (CDK) 4 amplification/overexpression and retinoblastoma...

    Juan Manuel Sepúlveda-Sánchez, Miguel Gil-Gil, ... Estela Pineda in Targeted Oncology
    Article 06 October 2020
  13. Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011–2022

    Background

    Tumor Treating Fields (TTFields) are alternating electric fields that disrupt cancer cell processes. TTFields therapy is approved for...

    Maciej M. Mrugala, Wenyin Shi, ... Martin Glas in Journal of Neuro-Oncology
    Article Open access 29 June 2024
  14. PCV chemotherapy alone for WHO grade 2 oligodendroglioma: prolonged disease control with low risk of malignant progression

    Introduction

    The role of chemotherapy alone in newly diagnosed WHO grade 2 oligodendroglioma after biopsy, incomplete or gross total resection remains...

    Jonathan Weller, Sophie Katzendobler, ... Joerg-Christian Tonn in Journal of Neuro-Oncology
    Article Open access 01 May 2021
  15. Comparative evaluation of intracranial oligodendroglioma and astrocytoma of similar grades using conventional and T1-weighted DCE-MRI

    Purpose

    This retrospective study was performed on a 3T MRI to determine the unique conventional MR imaging and T1-weighted DCE-MRI features of...

    Mamta Gupta, Abhinav Gupta, ... Rakesh Kumar Gupta in Neuroradiology
    Article 19 January 2021
  16. The oligodendroglial histological features are not independently predictive of patient prognosis in lower-grade gliomas

    The relevance of oligodendroglial histological features to patient prognoses is controversial. 93 LrGGs resected for about 2 decades were re-assessed...

    Eriel Sandika Pareira, Makoto Shibuya, ... Hikaru Sasaki in Brain Tumor Pathology
    Article 15 March 2022
  17. Bone metastases from a 1p/19q codeleted and IDH1-mutant anaplastic oligodendroglioma: a case report

    Background

    Oligodendroglioma is a rare type of primary brain tumor which, like other malignant gliomas, metastasizes very rarely even when in...

    Mickaël Burgy, Marie-Pierre Chenard, ... Roland Schott in Journal of Medical Case Reports
    Article Open access 28 June 2019
  18. Cortical high-flow sign on arterial spin labeling: a novel biomarker for IDH-mutation and 1p/19q-codeletion status in diffuse gliomas without intense contrast enhancement

    This study aimed to investigate whether arterial spin labeling (ASL) features allow differentiation of oligodendroglioma, IDH-mutant and...

    Koji Yamashita, Osamu Togao, ... Kousei Ishigami in Neuroradiology
    Article 27 June 2023
Did you find what you were looking for? Share feedback.